Stock Comparison
ARGX vs VRTX
argenx NV ADR and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$123.94B
P/E (TTM)
32.7
28.5
Forward P/E
30.4
25.7
Price/Sales
10.0
9.9
Price/Book
6.4
6.1
EV/EBITDA
27.6
23.2
Dividend Yield
—
—
Profitability
Net Margin
30.44%
35.40%
Operating Margin
27.34%
38.97%
Return on Equity
23.60%
23.50%
Return on Assets
11.60%
11.90%
Growth (YoY)
Revenue Growth
59.30%
12.50%
Earnings Growth
95.20%
8.00%
Price & Risk
Beta
-0.0
0.3
52-Week High
$939.68
$529.65
52-Week Low
$652.43
$376.62
Analyst Target
$1,085.78
$559.28
Compare ARGX and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.